Cited 0 times in
Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, JW | - |
dc.contributor.author | Park, S | - |
dc.contributor.author | Jung, JY | - |
dc.contributor.author | Kim, HA | - |
dc.contributor.author | Kwon, SR | - |
dc.contributor.author | Choi, ST | - |
dc.contributor.author | Kim, SS | - |
dc.contributor.author | Kim, SH | - |
dc.contributor.author | Suh, CH | - |
dc.date.accessioned | 2023-02-27T07:13:00Z | - |
dc.date.available | 2023-02-27T07:13:00Z | - |
dc.date.issued | 2022 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/24926 | - |
dc.description.abstract | BACKGROUND: We investigated the prevalence of and the factors associated with a high risk of osteoporotic fractures in Korean patients with ankylosing spondylitis (AS). METHODS: This was a multicenter, retrospective study including 219 AS patients from five university hospitals; the control group was selected by matching age and sex with those of the AS patients. The fracture risk was evaluated based on bone mineral density (BMD) measured by dual-energy X-ray absorptiometry and the fracture risk assessment tool (FRAX) with/without BMD. RESULTS: The mean age of the patients was 47.6 years, and 144 (65.8%) patients were men. According to the WHO criteria and FRAX with/without BMD, the candidates for pharmacological treatment were 44 (20.1%), 20 (13.2%), and 23 (15.1%) patients, respectively, significantly more than those in the healthy control group. Among them, the proportion of patients receiving osteoporosis treatment was 39.1-75%. In logistic regression analysis, menopause was an independent factor for the high risk of fracture according to the WHO criteria and FRAX with/without BMD. C-reactive protein level (odds ratio (OR) 3.8 and OR 6) and glucocorticoid use (OR 1.5 and OR 1.7) were associated with a high risk of osteoporotic fracture based on FRAX without BMD and osteoporosis diagnosed according to the WHO criteria. CONCLUSIONS: Our study suggests that both FRAX and WHO criteria may be complementary for treatment decisions to reduce osteoporotic fractures in patients with AS. | - |
dc.language.iso | en | - |
dc.title | Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool | - |
dc.type | Article | - |
dc.identifier.pmid | 35628957 | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146147 | - |
dc.subject.keyword | ankylosing spondylitis | - |
dc.subject.keyword | bone mineral density | - |
dc.subject.keyword | fracture risk assessment tool | - |
dc.subject.keyword | osteoporosis | - |
dc.subject.keyword | osteoporotic fracture | - |
dc.contributor.affiliatedAuthor | Kim, JW | - |
dc.contributor.affiliatedAuthor | Park, S | - |
dc.contributor.affiliatedAuthor | Jung, JY | - |
dc.contributor.affiliatedAuthor | Kim, HA | - |
dc.contributor.affiliatedAuthor | Suh, CH | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.3390/jcm11102830 | - |
dc.citation.title | Journal of clinical medicine | - |
dc.citation.volume | 11 | - |
dc.citation.number | 10 | - |
dc.citation.date | 2022 | - |
dc.citation.startPage | 2830 | - |
dc.citation.endPage | 2830 | - |
dc.identifier.bibliographicCitation | Journal of clinical medicine, 11(10). : 2830-2830, 2022 | - |
dc.identifier.eissn | 2077-0383 | - |
dc.relation.journalid | J020770383 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.